Submitted by Anonymous (not verified) on 21 October 2024 - 11:50
Human medicines European public assessment report (EPAR): Amyvid, florbetapir (18F), Date of authorisation: 14/01/2013, Revision: 15, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Amyvid, florbetapir (18F), Date of authorisation: 14/01/2013, Revision: 15, Status: Authorised